ストックスクリーナーアプリを入手
5.10
4.51%
0.22
アフターアワーズ：
5.10
Mannkind Corp (MNKD) 最新ニュース
FDA accepts application for MannKind inhaled insulin in kids - MassDevice
How MannKind Corporation stock responds to policy changesJuly 2025 Spike Watch & Safe Entry Point Identification - newser.com
MannKind (MNKD) Seeks FDA Approval for Afrezza in Younger Patien - GuruFocus
Is MannKind Corporation stock poised for growth2025 Technical Overview & Stepwise Swing Trade Plans - newser.com
MannKind (MNKD) Advances Inhaled Insulin for Pediatric Diabetes - GuruFocus
FDA accepts MannKind’s application for inhaled insulin in children - Investing.com
MannKind Corporation Submits Supplemental Biologics License Application for Needle-Free Afrezza Inhalation Powder for Pediatric Diabetes Treatment - Quiver Quantitative
Real time scanner hits for MannKind Corporation explainedMarket Trend Review & Free Reliable Trade Execution Plans - newser.com
MannKind Announces U.S. FDA Accepts for Review its Supplemental Biologics License Application (sBLA) for Inhaled Insulin (Afrezza) in Children and Adolescents Aged 4-17 Years Living with Diabetes - Yahoo Finance
HC Wainwright & Co. Reiterates Buy Rating for MNKD with $11 PT | MNKD Stock News - GuruFocus
MannKind Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
MannKind (NASDAQ:MNKD) Given "Hold (C)" Rating at Weiss Ratings - MarketBeat
Using data models to predict MannKind Corporation stock movement2025 Market Sentiment & Consistent Income Trade Ideas - newser.com
MannKind completes acquisition of scPharmaceuticals in $296.5 million deal - Investing.com
Risk adjusted return profile for MannKind Corporation analyzedWeekly Trade Analysis & Accurate Technical Buy Alerts - newser.com
Heatmap analysis for MannKind Corporation and competitorsJuly 2025 Spike Watch & Verified Swing Trading Watchlist - newser.com
How moving averages guide MannKind Corporation tradingWatch List & Weekly Momentum Picks - newser.com
MannKind (NASDAQ:MNKD) Upgraded at Zacks Research - MarketBeat
MannKind completes acquisition of scPharmaceuticals By Investing.com - Investing.com Canada
MannKind completes acquisition of scPharmaceuticals; SCPH to be delisted from Nasdaq - Investing.com
MannKind (MNKD) Completes Acquisition of scPharmaceuticals to Bo - GuruFocus
MannKind completes acquisition of scPharmaceuticals - Investing.com
MannKind Corporation Completes Acquisition of scPharmaceuticals Inc. to Enhance Revenue Growth and Expand Cardiometabolic Therapy Portfolio - Quiver Quantitative
MannKind Completes Acquisition of scPharmaceuticals, Accelerating Revenue Growth in Cardiometabolic Care - Yahoo Finance
>$370M annualized run rate: MannKind completes scPharmaceuticals acquisition, adds FUROSCIX - Stock Titan
A Fresh Look at MannKind (MNKD) Valuation Following Leadership Change with New Chief Medical Officer - simplywall.st
Does MannKind (NASDAQ:MNKD) Deserve A Spot On Your Watchlist? - Yahoo Finance
Why MannKind Corporation (NNFN) stock is trending on social mediaEarnings Summary Report & Safe Capital Growth Stock Tips - newser.com
How Dr. Ajay Ahuja’s Appointment at MannKind (MNKD) Has Changed Its Investment Story - simplywall.st
Assessing MannKind’s Share Price After FDA Clears Pediatric Use for Afrezza in 2025 - simplywall.st
Key metrics from MannKind Corporation’s quarterly dataRate Cut & Community Trade Idea Sharing - newser.com
Published on: 2025-10-02 20:45:52 - newser.com
Revolution Medicines hires Mirati, ALX vet Sandler - biocentury.com
MannKind Gets A Price Bump As Pipeline Progresses - Finimize
Is MannKind Corporation (NNFN) stock undervalued historicallyMarket Activity Summary & Daily Entry Point Trade Alerts - newser.com
Is MannKind Corporation a good long term investmentSector ETF Performance & Take Advantage of Momentum Stocks - earlytimes.in
MannKind (MNKD) Appoints New Chief Medical Officer - GuruFocus
MNKD Appoints New Chief Medical Officer to Strengthen Leadership Team - GuruFocus
MannKind appoints Ajay Ahuja as chief medical officer - Investing.com
MannKind Corporation Appoints Dr. Ajay Ahuja as Chief Medical Officer - Quiver Quantitative
Former Global Medical Head at Allergan: Dr. Ajay Ahuja Joins MannKind as Chief Medical Officer - Stock Titan
Will MannKind Corporation (NNFN) stock see insider accumulationJuly 2025 Rallies & Stock Timing and Entry Methods - newser.com
Will a bounce in MannKind Corporation offer an exitEarnings Overview Summary & Community Verified Swing Trade Signals - newser.com
Non Tuberculous Mycobacterial Infections Market Dynamics - openPR.com
MannKind (NASDAQ:MNKD) Shares Down 5%Time to Sell? - MarketBeat
MannKind (NASDAQ:MNKD) Earns Buy Rating from HC Wainwright - MarketBeat
Should you hold or exit MannKind Corporation nowWeekly Stock Recap & Scalable Portfolio Growth Ideas - newser.com
Price action breakdown for MannKind CorporationQuarterly Profit Report & Free Technical Confirmation Trade Alerts - newser.com
MannKind Corporation (NASDAQ:MNKD) Sees Significant Drop in Short Interest - MarketBeat
Insider Selling: MannKind (NASDAQ:MNKD) Insider Sells 47,000 Shares of Stock - MarketBeat
1.11%
大文字化:
|
ボリューム (24 時間):